Levomethadyl Acetate [Usan] en es it fr

Levomethadyl Acetate [Usan] Brand names, Levomethadyl Acetate [Usan] Analogs

Levomethadyl Acetate [Usan] Brand Names Mixture

  • No information avaliable

Levomethadyl Acetate [Usan] Chemical_Formula

C23H31NO2

Levomethadyl Acetate [Usan] RX_link

http://www.rxlist.com/cgi/generic2/levomethadyl.htm

Levomethadyl Acetate [Usan] fda sheet

Levomethadyl Acetate [Usan] msds (material safety sheet)

Levomethadyl Acetate [Usan] Synthesis Reference

No information avaliable

Levomethadyl Acetate [Usan] Molecular Weight

353.498 g/mol

Levomethadyl Acetate [Usan] Melting Point

No information avaliable

Levomethadyl Acetate [Usan] H2O Solubility

>15 mg/mL

Levomethadyl Acetate [Usan] State

Solid

Levomethadyl Acetate [Usan] LogP

6.139

Levomethadyl Acetate [Usan] Dosage Forms

Solution

Levomethadyl Acetate [Usan] Indication

LAAM is indicated for the treatment and management of opiate dependence. It is sometimes used to treat severe pain in terminal patients.

Levomethadyl Acetate [Usan] Pharmacology

LAAM is a synthetic synthetic opioid analgesic with multiple actions quantitatively similar to those as morphine, the most prominent of which involve the central nervous system and organs composed of smooth muscle. However, LAAM is more active and more toxic than morphine. The principal actions of therapeutic value are analgesia and sedation and detoxification or temporary maintenance in narcotic addiction. The LAAM abstinence syndrome, although qualitatively similar to that of morphine, differs in that the onset is slower, the course is more prolonged, and the symptoms are less severe.

Levomethadyl Acetate [Usan] Absorption

LAAM is rapidly absorbed from an oral solution.

Levomethadyl Acetate [Usan] side effects and Toxicity

Signs of overdose include apnea, circulatory collapse, pulmonary edema, cardiac arrest, and death.

Levomethadyl Acetate [Usan] Patient Information

No information avaliable

Levomethadyl Acetate [Usan] Organisms Affected

Humans and other mammals